SECOND TAKE
BLOOMBERG OPINION: Pressure builds to waive Covid-19 jab patents
Issue of intellectual property rights will be in spotlight at World Trade Organization meetings this week
04 May 2021 - 16:38
With patients in India dying in the streets and crematoriums melting from overuse, pressure is building on the US and other rich nations to waive patents so that anyone, anywhere can produce Covid-19 vaccines.
There’s no question that boosting global manufacturing and distribution of vaccines should be an overriding priority, but the argument about intellectual property (IP) is missing a crucial point. IP waivers, by themselves, won’t get the job done...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.